A Danish phase III trial has found that hypofractionated locoregional radiotherapy (40 Gy in 15 fractions over 3 weeks) was ...
A French retrospective study suggests that nirsevimab (Beyfortus), used to prevent respiratory syncytial virus (RSV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results